Exact(3)
The stimuli were presented during four blocks (with 20 trials each), each block beginning with a dummy trial [31].
16 This was a phase III non-inferiority, double blind, double dummy trial, which included sham monitoring of international normalised ratio and sham titration of vitamin K antagonists in the experimental group.
The ENGAGE AF-TIMI 48 (Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation Thrombolysis in Myocardial Infarction) trial is a randomized double blind double dummy trial that compared two different once daily doses (30 mg and 60 mg) to dose adjusted warfarin.
Similar(57)
No data were collected during dummy trials and participants were advised that the height of the raised surface would be varied throughout the study.
Despite "dummy trials" using different step heights to limit the effectiveness of using somatosensory feedback from previous trials to determine step height, maximum toe elevation and subsequent toe clearance reduced with repetition.
In addition, six "dummy trials" were included, where the height of the step was randomly adjusted by −10 mm or +5 mm every third trial to limit the effectiveness of using somatosensory feedback from previous trials to estimate the height of the step.
It remained on the screen until the second response was made with the left hand or until the response interval exceeded 2000 ms. Finally, valid feedback was presented for 500 ms. The experiment lasted for about 60 min and consisted of one block starting out with two dummy trials which were excluded from further analysis.
The experiment consisted of 324 trials in total (20 trials × 8 frequencies + 160 baseline trials + 4 initial dummy trials).
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial is a randomised, double-blind, double-dummy trial, evaluating anastrozole alone or in combination with tamoxifen compared with tamoxifen alone, as a 5-year adjuvant treatment for postmenopausal patients with early breast cancer.
This was a double-blinded, double-dummy trial of 199 mostly moderate- or high-risk dyslipidemic patients randomized to fluvastatin XL 80mg/dayy (n = 69), ezetimibe 10 mg/day (n = 66), or fluvastatin XL 80 mg/day plus ezetimibe 10 mg/day (n = 64) for 12 weeks.
In this double-dummy trial, intravenous therapy was administered over at least 15 minutes.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com